Skip to search formSkip to main contentSkip to account menu

Human Papillomavirus 16 E7 Peptide

Known as: HPV-16 E7, HPV-16 E7 Peptide, HPV16 E7 
A peptide vaccine consisting of amino acids 12 through 20 of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Objective. To identify characteristics of the cell‐mediated immune (CMI) response to human papillomavirus‐16 (HPV) E7 viral… 
2011
2011
BACKGROUND Vaccines capable of controlling tumor virus based infections are found difficult to develop due to the consistence… 
2011
2011
Objective: The human papillomavirus as an etiological agent of cervical cancer does not grow adequately in tissue culture systems… 
2010
2010
Morphine and ketorolac, two analgesics with different mechanisms, have been widely used in controlling cancer pain and… 
2006
2006
Human papillomavirus (HPV) infection is the most important risk factor for the development of cervical cancer. The oncogene E7… 
Highly Cited
1992
Highly Cited
1992
We have determined nucleotide sequences of the E7 open reading frame (ORF) of human papillomavirus type 16 (HPV-16) isolates…